Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting

---
identifier: "/us/fr/05-9765"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "05-9765"
section_name: "Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting"
positive_law: false
currency: "2005-05-17"
last_updated: "2005-05-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "05-9765"
document_type: "notice"
publication_date: "2005-05-17"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "70 FR 28311"
fr_volume: 70
---


#  Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease  Control and Prevention (CDC) announces the following meeting.

*Name:* Healthcare Infection Control Practices Advisory Committee.

*Times and Dates:* 8:30 a.m.-5 p.m., June 6, 2005; 8:30 a.m.-4 p.m., June 7, 2005.

*Place:* Sheraton Colony Square, 188 14th Street, NE., Atlanta, Georgia 30361.

*Status:* Open to the public, limited only by the space available.

*Purpose:* The Committee is charged with providing advice and guidance to the Secretary; the Assistant Secretary for Health; the Director, CDC; and the Director, National Center for Infectious Diseases (NCID), regarding (1) the practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections ( *e.g.* , nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and 3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.

*Matters to be Discussed:* Agenda items will include recommendations for the use of vancomycin; recommendations for isolation precautions to prevent transmission of infectious agents in healthcare settings; pandemic influenza planning for healthcare facilities; and updates on CDC activities of interest to the committee.

Agenda items are subject to change as priorities dictate.

*Contact Person For More Information:* Harriett Lynch, Committee Management Specialist, HICPAC, Division of Healthcare Quality Promotion, NCID, CDC, 1600 Clifton Road, NE, M/S A-07, Atlanta, Georgia 30333, telephone 404/498-1182.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: May 11, 2005.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.